Table 3 Patients with different surgical procedures
From: Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study
Characteristics | Total thyroidectomy (n = 1669) | Partial thyroidectomy (n = 382) | P-value |
|---|---|---|---|
Age | 55 ± 15.0 | 55 ± 16.5 | 0.136 |
Gender, (%) | 0.556 | ||
Male | 484 (29.0) | 105 (27.5) | |
Female | 1185 (71.0) | 277 (72.5) | |
Race, n (%) | 0.667 | ||
White | 1387 (83.1) | 309 (80.9) | |
Black | 148 (8.9) | 36 (9.4) | |
American Indian/Alaska Native, Asian/Pacific Islander | 113 (6.8) | 30 (7.9) | |
Unknown | 21 (1.3) | 7 (1.8) | |
SEER stage, n (%) | 0.023 | ||
Local | 1388 (83.2) | 340 (89.0) | |
Regional | 208 (12.5) | 35 (9.2) | |
Distant | 68 (4.1) | 6 (1.6) | |
Unspecified | 5 (0.3) | 1 (0.3) | |
Tumor multifocality, n (%) | 0.072 | ||
No | 1324 (79.3) | 317 (83.0) | |
Yes | 295 (17.7) | 50 (13.1) | |
Unspecified | 50 (3.0) | 15 (3.9) | |
Tumor extension, n (%) | 0.394 | ||
Intrathyroidal | 1420 (85.1) | 335 (87.7) | |
Extrathyroidal | 241 (14.4) | 46 (12.0) | |
Unspecified | 8 (0.5) | 1 (0.3) | |
T-stage, n (%) | 0.022 | ||
T1 | 391 (23.4) | 93 (24.3) | |
T2 | 566 (33.9) | 137 (35.9) | |
T3 | 577 (34.6) | 122 (31.9) | |
T4 | 80 (4.8) | 8 (2.1) | |
Unspecified | 55 (3.3) | 22 (5.8) | |
N-stage, n (%) | < 0.001 | ||
N0 | 1535 (92.0) | 361 (94.5) | |
N1 | 99 (5.9) | 6 (1.6) | |
Unspecified | 35 (2.1) | 15 (3.9) | |
M-stage, n (%) | 0.005 | ||
M0 | 1605 (96.2) | 368 (96.3) | |
M1 | 44 (2.6) | 3 (0.8) | |
Unspecified | 20 (1.2) | 11 (2.9) | |
Radiotherapy, n (%) | < 0.001 | ||
No | 557 (33.4) | 262 (68.6) | |
Radioactive iodine | 1033 (61.9) | 111 (29.1) | |
Unspecified | 79 (4.7) | 9 (2.4) | |